72 followers
Natalizumab vs IFN-beta:lower disability and relapse rate in MS patients
Natalizumab vs IFN-beta:lower disability and relapse rate in MS patients
RT @Steelers_VA: Worth the risks! Live once, live strong, live long! #MSWarrior #4for4 #HereWeGo https://t.co/GBjcVB4OHf
RT @OhioHealthMS: The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study…
The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study. https://t.co/Re9wXARbK9